Currently, among other matters, Peter represents the owners of a large affordable housing project located in Brooklyn, N.Y., in federal and state court litigation challenging rent increase orders issued by government authorities; a European fund manager in connection with a dispute arising out of foreign investment in an alternative energy project; and the general partner of a real estate limited partnership in a lawsuit brought by the putative assignee of certain limited partnership interests. Peter is also pro bono appellate counsel for a Dominican citizen who was awarded custody of her infant daughter by the New York courts following a proceeding in the Dominican Republic under the Hague Convention on the Civil Aspects of Child Abduction.
Peter served as lead national counsel for a pharmaceutical manufacturer in the fen/phen diet drug litigation, involving more than 7,000 individual and class action lawsuits filed in a federal MDL and state courts throughout the United States. He was also the court-appointed defense liaison counsel in the Ephedra MDL and a member of the defendants’ coordinating counsel. Peter served as national coordinating counsel for a manufacturer of generic methylphenidate and functioned in the same capacity in litigation involving claims that the use of a mercury-based preservative in childhood vaccines caused autism.
Peter has also represented clients in securities fraud and class actions; civil RICO actions; real estate litigation; foreclosure and other bank-related litigation; SEC enforcement proceedings; trademark infringement actions; and actions involving professional liability claims, sex and race discrimination claims, and alleged bankruptcy frauds.